Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Experience of Catheter Ablation Using Novel Ablation Technologies Associated With the Carto System for the Treatment of Symptomatic Paroxysmal and Persistent Atrial Fibrillation (NOVEL AF)

NCT05006456 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.

NCT NCT05006456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05006456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Experience of Catheter Ablation Using Novel Ablation Technologies Associated With the Carto System for the Treatment of Symptomatic Paroxysmal and Persistent Atrial Fibrillation (NOVEL AF)
Lead sponsor
Beijing Anzhen Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2022
Completion date
January 30, 2026
Enrollment
4,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation, persistent atrial fibrillation